富血小板纤维蛋白增强间隙桥接策略促进兔前交叉韧带修复
本研究在兔模型中评估富血小板纤维蛋白(PRF)增强修复策略促进前交叉韧带(ACL)中段撕裂生物学愈合的疗效,体外与体内评价PRF支架单独或联合兔韧带细胞对ACL原发愈合的生物学桥接效应。结果显示PRF条件培养基促进韧带细胞增殖、迁移及肌腱生成基因表达,PRF增强组修复组织形成并减少关节软骨损伤,结论认为PRF增强策略可促进稳定修复组织形成并提供间隙桥接。
要点
- PRF条件培养基促进培养兔韧带细胞增殖、迁移及I型、III型胶原和腱生蛋白表达。
- PRF增强组(B组和C组)在术后8周和12周观察到ACL修复组织且关节软骨损伤较少。
- 作者结论认为PRF增强策略可促进稳定修复组织形成并提供ACL修复间隙桥接。
核心结论
- 作者的PRF增强策略可促进稳定修复组织形成,从而为ACL修复提供间隙桥接。
研究设计与样本
- 受控实验室研究,体外评估PRF条件培养基对兔韧带细胞增殖、肌腱分化、迁移及肌腱特异性基质产生的影响。
- 在低冻干PRF(LPRF)补片上培养韧带细胞14天制备三维LPRF-细胞复合物,并用扫描电镜和组织学分析评估细胞-支架相互作用。
- 建立兔ACL中段撕裂模型并分3组:A组仅缝合修复,B组以LPRF增强原发修复桥接断端间隙,C组以LPRF-细胞复合物增强原发修复桥接断端间隙。
- 在术后第8周和第12周评估大体外观、磁共振成像和组织学分析结果。
主要发现
- PRF条件培养基促进培养韧带细胞增殖、迁移及肌腱生成基因(I型和III型胶原和腱生蛋白)表达。
- PRF在基质产生方面上调细胞肌腱分化。
- 三维培养中存活细胞在高密度下于LPRF支架表面形成层状结构,可见明显细胞长入和丰富胶原基质沉积。
- B组和C组膝关节中观察到ACL修复组织和较少的关节软骨损伤,提示PRF增强治疗相关的软骨保护现象。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We assessed the efficacy of a novel platelet-rich fibrin (PRF)-augmented repair strategy for promoting biological healing of an anterior cruciate ligament (ACL) midsubstance tear in a rabbit model. The biological gap-bridging effect of a PRF scaffold alone or in combination with rabbit ligamentocytes on primary ACL healing was evaluated both in vitro and in vivo. HYPOTHESIS: A PRF matrix can be implanted as a provisional fibrin-platelet bridging scaffold at an ACL defect to facilitate functional healing. STUDY DESIGN: Controlled laboratory study. METHODS: The biological effects of PRF on primary rabbit ligamentocyte proliferation, tenogenic differentiation, migration, and tendon-specific matrix production were investigated for treatment of cells with PRF-conditioned medium (PRFM). Three-dimensional (3D) lyophilized PRF (LPRF)-cell composite was fabricated by culturing ligamentocytes on an LPRF patch for 14 days. Cell-scaffold interactions were investigated under a scanning electron microscope and through histological analysis. An ACL midsubstance tear model was established in 3 rabbit groups: a ruptured ACL was treated with isolated suture repair in group A, whereas the primary repair was augmented with LPRF and LPRF-cell composite to bridge the gap between ruptured ends of ligaments in groups B and C, respectively. Outcomes-gross appearance, magnetic resonance imaging, and histological analysis-were evaluated in postoperative weeks 8 and 12. RESULTS: PRFM promoted cultured ligamentocyte proliferation, migration, and expression of tenogenic genes (type I and III collagen and tenascin). PRF was noted to upregulate cell tenogenic differentiation in terms of matrix production. In the 3D culture, viable cells formed layers at high density on the LPRF scaffold surface, with notable cell ingrowth and abundant collagenous matrix depositions. Moreover, ACL repair tissue and less articular cartilage damage were observed in knee joints in groups B and C, implying the existence of a chondroprotective phenomenon associated with PRF-augmented treatment. CONCLUSION: Our PRF-augmented strategy can facilitate the formation of stable repair tissue and thus provide gap-bridging in ACL repair. CLINICAL RELEVANCE: From the translational viewpoint, effective primary repair of the ACL may enable considerable advancement in therapeutic strategy for ACL injuries, particularly allowing for proprioception retention and thus improved physiological joint kinematics.
引用
- Weng PW, Chen CH, Lin YC, et al. Platelet-Rich Fibrin-Augmented Gap-Bridging Strategy in Rabbit Anterior Cruciate Ligament Repair. Am J Sports Med. 2023. PMID: 36752674. doi:10.1177/03635465221149993
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。